In the article “The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy”,[1] which appeared in Volume 95, Issue 33 of Medicine, some affiliation information was originally given incorrectly. The article has since been corrected online.
Reference
- 1.Tai H, Wang M-Y, Zhao Y-P, et al. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy. Medicine. 2016. 95:e4541. [DOI] [PMC free article] [PubMed] [Google Scholar]